Literature DB >> 10982344

Overexpression of essential splicing factor ASF/SF2 blocks the temporal shift in adenovirus pre-mRNA splicing and reduces virus progeny formation.

M Molin1, G Akusjärvi.   

Abstract

Expression of cytoplasmic mRNA from most adenovirus transcription units is subjected to a temporal regulation at the level of alternative pre-mRNA splicing. The general tendency is that splice site selection changes from proximal to distal late after infection. Interestingly, ASF/SF2, which is a prototypical member of the SR family of splicing factors, has the opposite effect on splice site selection, inducing an increase in proximal splice site usage. We have previously shown that SR proteins late during an adenovirus infection become partially inactivated as splicing regulatory proteins. A prediction from these results is that overexpression of an SR protein, such as ASF/SF2, during virus growth will interfere with virus replication by disturbing the balance of functional and nonfunctional ASF/SF2 in the infected cell. To test this hypothesis, we reconstructed a recombinant adenovirus expressing ASF/SF2 under the transcriptional control of a regulated promoter. The results show that, as predicted, induction of ASF/SF2 during lytic virus growth prevents the early to late shift in mRNA expression from both early (E1A and E1B) and late (L1) transcription units. Furthermore, ASF/SF2 overexpression blocks viral DNA replication and reduces selectively cytoplasmic accumulation of major late mRNA, resulting in a lower virus yield. Collectively, our results provide additional support for the hypothesis that viral control of SR protein function is important for the proper expression of viral proteins during lytic virus growth.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10982344      PMCID: PMC102096          DOI: 10.1128/jvi.74.19.9002-9009.2000

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  47 in total

1.  Control of adenovirus major late gene expression at multiple levels.

Authors:  S Larsson; C Svensson; G Akusjärvi
Journal:  J Mol Biol       Date:  1992-05-20       Impact factor: 5.469

Review 2.  Adenovirus DNA replication.

Authors:  P C Van der Vliet
Journal:  Curr Top Microbiol Immunol       Date:  1995       Impact factor: 4.291

3.  Human adenovirus encodes two proteins which have opposite effects on accumulation of alternatively spliced mRNAs.

Authors:  K Nordqvist; K Ohman; G Akusjärvi
Journal:  Mol Cell Biol       Date:  1994-01       Impact factor: 4.272

4.  Distinct functions of SR proteins in alternative pre-mRNA splicing.

Authors:  A M Zahler; K M Neugebauer; W S Lane; M B Roth
Journal:  Science       Date:  1993-04-09       Impact factor: 47.728

5.  Regulation of alternative splicing in vivo by overexpression of antagonistic splicing factors.

Authors:  J F Cáceres; S Stamm; D M Helfman; A R Krainer
Journal:  Science       Date:  1994-09-16       Impact factor: 47.728

6.  Regulation of alternative pre-mRNA splicing by hnRNP A1 and splicing factor SF2.

Authors:  A Mayeda; A R Krainer
Journal:  Cell       Date:  1992-01-24       Impact factor: 41.582

7.  Modulation of exon skipping and inclusion by heterogeneous nuclear ribonucleoprotein A1 and pre-mRNA splicing factor SF2/ASF.

Authors:  A Mayeda; D M Helfman; A R Krainer
Journal:  Mol Cell Biol       Date:  1993-05       Impact factor: 4.272

8.  Specific interactions between proteins implicated in splice site selection and regulated alternative splicing.

Authors:  J Y Wu; T Maniatis
Journal:  Cell       Date:  1993-12-17       Impact factor: 41.582

9.  Regulation of mammalian spliceosome assembly by a protein phosphorylation mechanism.

Authors:  J E Mermoud; P T Cohen; A I Lamond
Journal:  EMBO J       Date:  1994-12-01       Impact factor: 11.598

10.  Pathways for selection of 5' splice sites by U1 snRNPs and SF2/ASF.

Authors:  I C Eperon; D C Ireland; R A Smith; A Mayeda; A R Krainer
Journal:  EMBO J       Date:  1993-09       Impact factor: 11.598

View more
  18 in total

Review 1.  T' proteins influence JC virus biology.

Authors:  Richard J Frisque; Brigitte Bollag; Shiva K Tyagarajan; Lisa H Kilpatrick
Journal:  J Neurovirol       Date:  2003       Impact factor: 2.643

2.  Viral regulation of mRNA export.

Authors:  Rozanne M Sandri-Goldin
Journal:  J Virol       Date:  2004-05       Impact factor: 5.103

3.  Adenovirus vector designed for expression of toxic proteins.

Authors:  D Edholm; M Molin; E Bajak; G Akusjärvi
Journal:  J Virol       Date:  2001-10       Impact factor: 5.103

4.  Suppression of Adenovirus Replication by Cardiotonic Steroids.

Authors:  Filomena Grosso; Peter Stoilov; Clifford Lingwood; Martha Brown; Alan Cochrane
Journal:  J Virol       Date:  2017-01-18       Impact factor: 5.103

5.  JC virus T' proteins encoded by alternatively spliced early mRNAs enhance T antigen-mediated viral DNA replication in human cells.

Authors:  C Prins; R J Frisque
Journal:  J Neurovirol       Date:  2001-06       Impact factor: 2.643

6.  A gene similar to the human hyaluronan-mediated motility receptor (RHAMM) gene is upregulated during Porcine Circovirus type 2 infection.

Authors:  Ana Bratanich; Alain Blanchetot
Journal:  Virus Genes       Date:  2006-04       Impact factor: 2.332

7.  Acetylated Tat regulates human immunodeficiency virus type 1 splicing through its interaction with the splicing regulator p32.

Authors:  Reem Berro; Kylene Kehn; Cynthia de la Fuente; Anne Pumfery; Richard Adair; John Wade; Anamaris M Colberg-Poley; John Hiscott; Fatah Kashanchi
Journal:  J Virol       Date:  2006-04       Impact factor: 5.103

8.  Human immunodeficiency virus type 2 Gag interacts specifically with PRP4, a serine-threonine kinase, and inhibits phosphorylation of splicing factor SF2.

Authors:  Erin M Bennett; Andrew M L Lever; Jane F Allen
Journal:  J Virol       Date:  2004-10       Impact factor: 5.103

9.  Genome-wide analysis of alternative pre-mRNA splicing in Arabidopsis thaliana based on full-length cDNA sequences.

Authors:  Kei Iida; Motoaki Seki; Tetsuya Sakurai; Masakazu Satou; Kenji Akiyama; Tetsuro Toyoda; Akihiko Konagaya; Kazuo Shinozaki
Journal:  Nucleic Acids Res       Date:  2004-09-27       Impact factor: 16.971

10.  Rescue and production of vaccine and therapeutic adenovirus vectors expressing inhibitory transgenes.

Authors:  Jason G D Gall; Alena Lizonova; Damodar EttyReddy; Duncan McVey; Mohammed Zuber; Imre Kovesdi; Barbara Aughtman; C Richter King; Douglas E Brough
Journal:  Mol Biotechnol       Date:  2007-03       Impact factor: 2.695

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.